Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16040381rdf:typepubmed:Citationlld:pubmed
pubmed-article:16040381lifeskim:mentionsumls-concept:C0021083lld:lifeskim
pubmed-article:16040381lifeskim:mentionsumls-concept:C0254610lld:lifeskim
pubmed-article:16040381lifeskim:mentionsumls-concept:C1332717lld:lifeskim
pubmed-article:16040381lifeskim:mentionsumls-concept:C1706438lld:lifeskim
pubmed-article:16040381lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:16040381lifeskim:mentionsumls-concept:C0085358lld:lifeskim
pubmed-article:16040381lifeskim:mentionsumls-concept:C1413244lld:lifeskim
pubmed-article:16040381lifeskim:mentionsumls-concept:C2698600lld:lifeskim
pubmed-article:16040381lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:16040381pubmed:issue1lld:pubmed
pubmed-article:16040381pubmed:dateCreated2005-7-25lld:pubmed
pubmed-article:16040381pubmed:abstractTextIL-15 is a pleiotropic cytokine that plays an important role in both the innate and adaptive immune system. IL-15 promotes the activation of neutrophils and macrophages, and is critical to DC function. In addition, IL-15 is essential to the development, homeostasis, function and survival of natural killer (NK) cells, NK T (NKT) cells and CD8+ T cells. Based on these properties, IL-15 has been proposed as a useful cytokine for immunotherapy. It is currently being investigated in settings of immune deficiency, for the in vitro expansion of T and NK cells, as well as an adjuvant for vaccines. In this paper, we will review the targeting of IL-15 for immunotherapy, with a particular emphasis on its effects on CD8+ T cells.lld:pubmed
pubmed-article:16040381pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16040381pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16040381pubmed:languageenglld:pubmed
pubmed-article:16040381pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16040381pubmed:citationSubsetIMlld:pubmed
pubmed-article:16040381pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16040381pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16040381pubmed:statusMEDLINElld:pubmed
pubmed-article:16040381pubmed:issn1465-3249lld:pubmed
pubmed-article:16040381pubmed:authorpubmed-author:DiabAAlld:pubmed
pubmed-article:16040381pubmed:authorpubmed-author:CohenA DADlld:pubmed
pubmed-article:16040381pubmed:authorpubmed-author:AlpdoganOOlld:pubmed
pubmed-article:16040381pubmed:authorpubmed-author:PeralesM-AMAlld:pubmed
pubmed-article:16040381pubmed:issnTypePrintlld:pubmed
pubmed-article:16040381pubmed:volume7lld:pubmed
pubmed-article:16040381pubmed:ownerNLMlld:pubmed
pubmed-article:16040381pubmed:authorsCompleteYlld:pubmed
pubmed-article:16040381pubmed:pagination23-35lld:pubmed
pubmed-article:16040381pubmed:dateRevised2008-4-24lld:pubmed
pubmed-article:16040381pubmed:meshHeadingpubmed-meshheading:16040381...lld:pubmed
pubmed-article:16040381pubmed:meshHeadingpubmed-meshheading:16040381...lld:pubmed
pubmed-article:16040381pubmed:meshHeadingpubmed-meshheading:16040381...lld:pubmed
pubmed-article:16040381pubmed:meshHeadingpubmed-meshheading:16040381...lld:pubmed
pubmed-article:16040381pubmed:meshHeadingpubmed-meshheading:16040381...lld:pubmed
pubmed-article:16040381pubmed:meshHeadingpubmed-meshheading:16040381...lld:pubmed
pubmed-article:16040381pubmed:meshHeadingpubmed-meshheading:16040381...lld:pubmed
pubmed-article:16040381pubmed:meshHeadingpubmed-meshheading:16040381...lld:pubmed
pubmed-article:16040381pubmed:meshHeadingpubmed-meshheading:16040381...lld:pubmed
pubmed-article:16040381pubmed:meshHeadingpubmed-meshheading:16040381...lld:pubmed
pubmed-article:16040381pubmed:meshHeadingpubmed-meshheading:16040381...lld:pubmed
pubmed-article:16040381pubmed:year2005lld:pubmed
pubmed-article:16040381pubmed:articleTitleIL-15: targeting CD8+ T cells for immunotherapy.lld:pubmed
pubmed-article:16040381pubmed:affiliationMemorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.lld:pubmed
pubmed-article:16040381pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16040381pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:16040381pubmed:publicationTypeReviewlld:pubmed
pubmed-article:16040381pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:16040381pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16040381lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16040381lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16040381lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16040381lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16040381lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16040381lld:pubmed